269 related articles for article (PubMed ID: 21157908)
1. Managing hyponatremia in patients with heart failure.
Greenberg B
J Hosp Med; 2010; 5 Suppl 3():S33-9. PubMed ID: 21157908
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
Nemerovski C; Hutchinson DJ
Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
[TBL] [Abstract][Full Text] [Related]
3. Hyponatremia: current treatment strategies and the role of vasopressin antagonists.
Cawley MJ
Ann Pharmacother; 2007 May; 41(5):840-50. PubMed ID: 17405824
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
LeJemtel TH; Serrano C
Int J Cardiol; 2007 Aug; 120(1):1-9. PubMed ID: 17346825
[TBL] [Abstract][Full Text] [Related]
5. Managing hyponatremia in cirrhosis.
Ross E; Sigal SH
J Hosp Med; 2010; 5 Suppl 3():S8-17. PubMed ID: 21157909
[TBL] [Abstract][Full Text] [Related]
6. Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients.
Lin TE; Adams KF; Patterson JH
Heart Fail Clin; 2014 Oct; 10(4):607-20. PubMed ID: 25217436
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of vasopressin receptor antagonists.
Ali F; Guglin M; Vaitkevicius P; Ghali JK
Drugs; 2007; 67(6):847-58. PubMed ID: 17428103
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin receptor antagonists.
Greenberg A; Verbalis JG
Kidney Int; 2006 Jun; 69(12):2124-30. PubMed ID: 16672911
[TBL] [Abstract][Full Text] [Related]
9. Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
Ali F; Raufi MA; Washington B; Ghali JK
Cardiovasc Drug Rev; 2007; 25(3):261-79. PubMed ID: 17919259
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin dysregulation and hyponatremia in hospitalized patients.
Multz AS
J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
[TBL] [Abstract][Full Text] [Related]
11. Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism.
Rosner MH; Ronco C
Congest Heart Fail; 2010 Jul; 16 Suppl 1():S7-14. PubMed ID: 20653716
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin-receptor antagonists in heart failure.
Schweiger TA; Zdanowicz MM
Am J Health Syst Pharm; 2008 May; 65(9):807-17. PubMed ID: 18436727
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms, risks, and new treatment options for hyponatremia.
Ghali JK
Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
[TBL] [Abstract][Full Text] [Related]
14. [Vasopressin receptor antagonists and heart failure].
Haass M
Ther Umsch; 2009 Nov; 66(11):735-40. PubMed ID: 19885790
[TBL] [Abstract][Full Text] [Related]
15. AVP receptor antagonists as aquaretics: review and assessment of clinical data.
Verbalis JG
Cleve Clin J Med; 2006 Sep; 73 Suppl 3():S24-33. PubMed ID: 16970150
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
Farmakis D; Filippatos G; Kremastinos DT; Gheorghiade M
Curr Heart Fail Rep; 2008 Jun; 5(2):91-6. PubMed ID: 18765079
[TBL] [Abstract][Full Text] [Related]
17. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
Rai A; Whaley-Connell A; McFarlane S; Sowers JR
Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
[TBL] [Abstract][Full Text] [Related]
18. Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
Patel GP; Balk RA
Clin Ther; 2007 Feb; 29(2):211-29. PubMed ID: 17472815
[TBL] [Abstract][Full Text] [Related]
19. AVP receptor antagonists in patients with CHF.
Kumar SK; Mather PJ
Heart Fail Rev; 2009 Jun; 14(2):83-6. PubMed ID: 18766439
[TBL] [Abstract][Full Text] [Related]
20. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
Goldsmith SR
Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
